enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: SCHEDULE 13G/A
Filing Date: 14 May 2026Report Date:
Accepted: 14 May 2026 08:30 a.m.
Accession Number: 0001373604-26-000042
File Number: 005-94211
Film Number: 26976489